ClinConnect ClinConnect Logo
Search / Trial NCT05403892

Reliability and Validity of a New Ankle Dorsiflexion Lunge Test Using a Level Laser.

Launched by UNIVERSITY OF BOLOGNA · May 31, 2022

Trial Information

Current as of May 02, 2025

Unknown status

Keywords

Level Laser Dorsiflexion Lunge Test Ankle

ClinConnect Summary

The dorsiflexion lunge test or knee-to-wall test (DLT) measure the range of movement of weight bearing ankle dorsiflexion. This test is frequently used in sport setting, in order to identify ankle limitations which could lead to possible injuries or joint overloads.

DLT is a cheap and simple measurement method to assess the ankle dorsiflexion, however clinicians find possible bias that reduce the usability of this test.

In order to remove this bias, this study suggests a new measurement method carried out by a level laser to create a virtual wall (the vertical red line produced by the las...

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • male teenagers basketball players enrolled in a competitive sports club;
  • teenagers whose parents have signed the privacy and consent forms.
  • Exclusion Criteria:
  • athletes who have suffered in the last 3 months of lower limb musculoskeletal disorders such as pain for more than 7 days (ankle distortion outcomes, leg/foot fractures, plantar heel pain, metatarsalgias, etc);
  • athletes who have undergone surgery on their lower limb.

About University Of Bologna

The University of Bologna, one of the oldest and most prestigious academic institutions in the world, is dedicated to advancing knowledge and innovation in the field of healthcare through rigorous clinical research. With a strong emphasis on interdisciplinary collaboration and cutting-edge methodologies, the university sponsors a diverse range of clinical trials aimed at enhancing patient outcomes and contributing to the scientific community. Its commitment to ethical standards and regulatory compliance ensures that all trials are conducted with the utmost integrity, fostering an environment of trust and excellence in clinical research.

Locations

Bologna, , Italy

Patients applied

0 patients applied

Trial Officials

Tommaso Torriglia

Principal Investigator

Università degli studi di Bologna

Pillastrini Paolo

Study Director

Università degli studi di Bologna

Silvia Pozzan

Study Chair

Università degli studi di Bologna

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials